BMO initiates Andersen Group stock coverage citing growth potential

BMO Capital initiated Andersen Group (NYSE: ANDG) at Market Perform with a $58 price target, citing above-peer organic growth, pricing power and an acquisition pipeline, while noting its premium valuation already reflects much of the upside. Andersen Global's Q2 revenue rose 23.7% year over year to $217.7 million and adjusted EBITDA increased 54% to $45.9 million, though diluted EPS was negative $0.09. ANDG has returned 139% over the past year, trades at 32.15x earnings near its 52-week high, and is pursuing a secondary sale of 4.28 million shares from existing holders with no proceeds to the company.

Analysis

The investable issue is not growth durability but conversion of that growth into per-share earnings and free cash flow. A premium multiple can be sustained for an asset-light advisory consolidator only if acquired practices retain clients and partners while organic growth remains above the acquisition-adjusted base; otherwise, compensation inflation and integration costs will compress EBITDA conversion before revenue growth visibly slows. The reported loss despite strong adjusted EBITDA makes stock-based compensation, amortization, transaction costs, and tax normalization the key diligence items rather than headline revenue momentum.

Near term, the secondary creates a technical overhang: selling-stockholder supply can cap upside even if fundamentals remain intact, particularly if the effective float is limited. Over the next 1-3 months, monitor completion of the greenshoe, daily traded value, insider/partner selling, and whether the deal prices at a discount; these will determine whether a post-deal dislocation offers an entry point. The claimed acquisition pipeline is strategically valuable only if purchase multiples stay below the company’s trading multiple and acquired revenue does not require disproportionately high partner payouts.

The contrarian view is that the market may be treating private-wealth exposure as recurring, countercyclical revenue when it is partly tied to liquidity events, estate planning cycles, and private-market fundraising. A weaker IPO/M&A environment or a risk-asset drawdown would hit new client formation and advisory demand with a lag, while fixed partner compensation limits downside flexibility. Conversely, demonstrated cross-selling into adjacent tax, legal, and valuation services could justify further multiple expansion relative to slower-growth consulting proxies such as ACN.

Key Decisions for Investors

• No immediate directional position in ANDG until public-float, secondary pricing, net-debt, and reconciliation from adjusted EBITDA to operating cash flow are verified; the data set contains entity-level inconsistencies that materially affect underwriting confidence.
• Set a 1-3 month long-entry alert for ANDG only after the secondary and any greenshoe are fully absorbed and management reiterates organic-growth and margin guidance. Underwrite a position only if cash conversion supports the premium valuation; exit on a meaningful organic-growth deceleration or further dilution without commensurate EBITDA growth.
• For a relative-value expression after verification, consider long ANDG / short ACN in equal beta-adjusted dollars if ANDG demonstrates sustained organic growth materially above ACN while maintaining EBITDA margins. The pair fails if acquisition-related compensation and amortization prevent per-share EPS growth from exceeding the larger peer.
• Do not use APP or SMCI as read-through trades: their inclusion is promotional screening context rather than an operating or valuation linkage to ANDG.